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Expansion of breast cancer stem cells with fibrous
scaﬀolds†
Sheng Feng,a Xinrui Duan,a Pang-Kuo Lo,b Shou Liu,b Xinfeng Liu,c Hexin Chen*b
and Qian Wang*a
Cancer stem cells (CSCs) are hypothesized as tumor-initiating cells within tumors and main contributors
of tumor growth, metastasis and recurrence. Mammary cancer cells, MCF-7 cells, were cultured on 3D
polycaprolactone (PCL) fibrous scaﬀolds, showing an increased proportion of CSCs. The expression of
stem cell markers, including OCT3/4 and SOX2, and breast CSC-specific markers, SOX4 and CD49f, was
significantly upregulated, and the mammosphere-forming capability in cells cultured on PCL fibrous
scaﬀolds increased. The fibrous scaﬀolds also induced the elongation of MCF-7 cells and extended cell
proliferation. The increase of CSC properties after being cultured on fibrous scaﬀolds was further
confirmed with two luminal-type mammary cell lines, T47D and SK-BR-3, and a basal-type cell line,
MDA-MB-231, by ALDEFLUOR assay and mammosphere formation assay. Moreover, we observed the
upregulation of epithelial to mesenchymal transition and increased invasive capability in cells cultured
on PCL fibrous scaﬀolds. These data suggest that the increase of CSC proportion in a 3D culture system
may account for the enhanced malignancy. Therefore, our PCL fibrous scaﬀolds can potentially be used
for CSCs enrichment and anti-cancer drug screening.
Insight, innovation, integration
Three dimensional (3D) culture systems have been utilized in studies of cancer metastasis and anti-tumor drug screening. Accumulating evidence indicates
that cancer cells in 3D culture displayed higher malignancy and invasive capability compared to their counterparts in two-dimensional culture. In the present
paper, we have fabricated a 3D polycaprolactone fibrous scaﬀold using an electrospinning process to evaluate how CSCs proportion in breast cancer cell
lines responds to this 3D culture. Functional assay and gene profiling together indicate that culture on fibrous scaﬀolds increased CSCs and induced
epithelial-mesenchymal-transition. This work provides a better understanding of how a 3D culture condition aﬀects cancer cells behavior as a mixture of CSCs
and non-CSCs. Thus, this knowledge potentially enlightens the design of novel biomaterials for the enrichment of CSCs, and eventually for drug screening
targeting CSCs.
Introduction
Cells cultured in vitro in two dimensional (2D) tissue culture
plastics (TCP) lack the structural architecture necessary for
proper cell–cell and cell–matrix interactions that exist in vivo.1–3
The complexity of the in vivo system, being composed of
many uncontrollable factors, such as immune response, endo-
genous growth factors, hemodynamics and mechanical cues,
complicates research on eﬀects of individual factors on cell
behaviours. On the other hand, although rodent animal models
are relatively reliable systems for human cancer research and
have been used for several decades,4–7 the significant diﬀerence
in telomerase regulation between humans and rodents makes
transgenic and inducible mouse cancer models questionable
in terms of replicating the human cancers.8 Hence, three-
dimensional (3D) cell culture models emerged to bridge the
gap between in vivo human cancer studies and in vitro 2D cell
culture models, as well as animal models.
The fabrication of 3D scaﬀolds for the study of tumor cells
in vitro has adopted techniques from developed fields of tissue
engineering.1,9,10 Among those techniques, the electrospinning
process is a simple and rapid method to generate scaﬀolds with
fibres range from micrometer to nanometer in diameter.11
Although cells in electrospun fibrous scaﬀolds often adhere
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to the surface with minimum penetration, researchers consider
these scaﬀolds as a 3D-like culture system because cells are
able to acquire the nutrition and extracellular signal three
dimensionally.12 Among various natural and synthetic poly-
mers available for the electrospinning process, poly(e-caprolac-
tone) (PCL) has attracted interest from researchers due to its
low melting temperature, good blend-compatibility, FDA
approval, and low cost.13 Nano and microscale fibrous scaﬀolds
obtained by electrospinning are ideal for 3D cell culture,
because their structures are similar to components in the
extracellular matrix, providing essential cues for cellular
survival, proliferation, organization, and function.12
Tumor cells grown in 3D scaﬀolds tend to develop the
morphologies and phenotypes observed in vivo14–16 and dis-
played higher invasive capability, and increased drug resistance
relative to cells in a 2D culture condition.17,18 However, the
mechanism of those alterations is still unclear. Recent research
has revealed that extracellular matrix (ECM) proteins can be
either coated in 2D dishes or fabricated into 3D scaﬀolds for
the enhancement and maintenance of the stemness properties
of cancer cells.19,20
Cancer stem cells (CSCs) are rare subpopulations that have
the capability to initiate tumor growth. Recent research has
revealed that CSCs are responsible for metastasis,21 chemo-
resistance,22 and radio-resistance.23 In the present study, we
hypothesized that the electrospun PCL fibrous scaﬀolds them-
selves without any protein component can increase CSCs
population. Using aldehyde dehydrogenase (ALDH) activity as
a CSCs marker24 and mammosphere formation assay,25 we
found that MCF-7, T47D, SK-BR-3 and MDA-MB-231 cells
cultured on electrospun PCL fibrous scaﬀolds increased the
CSCs population. The enhanced invasiveness and upregulation
of epithelial-to-mesenchymal transition (EMT) markers indi-
cate that cells were undergoing EMT, which might trigger the
transformation of non-stem cancer cells to CSCs.26
Results and discussion
Fabrication of the electrospun PCL fibrous scaﬀolds
PCL fibrous scaﬀolds were fabricated using a home-made electro-
spinning apparatus. For electrospun scaﬀolds to be reproduced,
the important parameters of electrospinning were recorded and
illustrated (Fig. 1a). With a stationary collector placed at 10 cm
underneath the tip, random fibrous scaﬀolds were obtained,
and no preferred fibre orientation was observed under scanning
electron microscope (SEM) (Fig. 1b). The average fibre diameter
calculated by Image J software was 1.63  0.36 mm and the
diameter distribution of this PCL scaﬀold ranged from 0.76 to
2.35 mm (Fig. 1c).
Although in diseases or during the movement, the ECM will
be reorganized in aligned orientation, the major component of
ECM, collagen fibres, usually randomly surrounded the breast
epithelial cells,27 which is similar to the organization of the
electrospun PCL random fibrous scaﬀolds. Our lab found that
luminal-type cell line MCF-7 maintained cell–cell contact and
random orientation on aligned fibrous scaﬀolds, indicating
less impacts of the aligned fibre on the cells.28 The aligned
fibre orientation will introduce the mechanical stretch on the
cells, which might complicate the interpretation of results.
Therefore, in this study we use random orientation fibrous
scaﬀolds for cell culture.
Cellular morphology and growth on electrospun PCL 3D
scaﬀolds
MCF-7 cells successfully propagated on PCL fibrous scaﬀolds.
Fluorescence microscopy revealed diﬀerent morphologies between
MCF-7 cells cultured on electrospun PCL fibrous scaﬀolds and
TCP (Fig. 2). Cells on TCP exhibited trigonal or polygonal morpho-
logies, whereas cells on PCL fibrous scaﬀolds showed round
shuttle-like shape. We also observed similar results in T47D,
SK-BR-3, and MDA-MB-231 cells (Fig. S1, ESI†). Relative to cells
on TCP with a spreading-out morphology, cells on PCL fibrous
scaﬀolds displayed a smaller F-actin staining area and round-like
shape. This might be because fibres surrounding cells limited
cells spreading and cells increased in thickness (Fig. S2, ESI†).
We utilized CellTiter-Blue assay to measure cell growth on
PCL scaﬀolds. On day 7, MCF-7 cells on TCP and fibrous
scaﬀolds proliferated to 15.00  0.48-fold and 13.87  0.56-
fold relative to day 1, respectively. There was no statistically
significant diﬀerence in the proliferation rate between cells on
TCP and PCL fibrous scaﬀolds during the first 7 days. However,
on day 9, cells cultured on TCP reached a plateau, whereas cells
Fig. 1 PCL fibrous scaﬀolds were fabricated by the electrospinning process. (a) The schematic illustration of electrospinning setup. (b) The SEM image of the
electrospun PCL fibrous scaﬀold. Scale bar indicates 100 mm. (c) The distribution of the fiber diameter on PCL fibrous scaﬀolds fabricated in the described setting.
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on PCL fibrous scaﬀolds continued propagating to 17.58 
1.43-fold relative to day 1 (Fig. 3). Considering the seeding cell
densities were the same in these two culture systems, the
discrepancy might come from the expanding space for cell
growth in 3D PCL fibrous scaﬀolds, because some of the cells
migrated through the pores and grew under layers of the fibres
(Movie S1, ESI†). We also observed a similar trend in MDA-MB-
231 cells (Fig. S3, ESI†).
Culturing breast cancer cell lines on PCL fibrous scaﬀolds
induces the expansion of the CSC subpopulation
The CSC theory postulates that a small group of cells, which is
selected by specific combination of markers, are responsible for
the initiation and maintenance of tumors. Chen and his collea-
gues found that MCF-7 cells in 3D collagen scaﬀolds displayed
enhanced stemness relative to their counterparts in 2D culture.20
The collagen scaﬀolds provide not only a 3D culture scaﬀold,
but also a microenvironment with protein–protein interactions
between membrane proteins of MCF-7 cells and collagen. In this
study, the unmodified electrospun PCL scaﬀolds exclude the
protein–protein interaction between cells and scaﬀolds. We cul-
tured MCF-7 cells on PCL fibrous scaﬀolds to test how this fibrous
scaﬀold culture condition aﬀects the size of CSCs population.
Aldehyde dehydrogenase, which is a detoxifying enzyme
responsible for the oxidation of intracellular aldehyde, may
play a role in early diﬀerentiation of stem cells through its role
in oxidizing retinol to retinoic acid.29 Accumulating data
indicates that ALDH expression is related to cells with
enhanced tumorigenic and metastatic potential.30–32 In addition,
based on ALDH activity, Ginestier and colleagues successfully
isolated CSCs from human breast tumors, and the expression of
ALDH1 was considered as a predictor of clinical outcomes in
breast cancer patients.24 We utilized the ALDEFLUOR assay to
assess the proportion of CSCs in breast cancer cells from PCL
fibrous scaﬀolds and TCP respectively.33 The ratio of ALDH-
positive population of MCF-7 cells increased to 6.33  0.55% in
3D PCL scaﬀolds relative to 2.00  0.04% in 2D TCP after 6 days
culture without passage (Fig. 4a and d). We also assessed CSCs
in two other luminal-type cell lines, T47D and SK-BR-3, from
PCL fibrous scaﬀolds and TCP. The proportion of ALDH-
positive cells in T47D and SK-BR-3 increased to 6.80  0.58%
and 18.27  1.73% on PCL fibrous scaﬀolds from 1.82  0.74%
and 7.22  0.19% on TCP, respectively (Fig. 4).
Previous research reported that mammary epithelial
stem and progenitor cells can survive and propagate in an
Fig. 2 Fluorescence microscopy images of MCF-7 cells cultured in 2D tissue culture plastics (a–c) and 3D PCL fibrous scaﬀolds (d–f). Blue indicates nuclei (DAPI); red
indicates F-actin (rhodamine-phalloidin). All scale bars indicate 100 mm.
Fig. 3 The proliferations of MCF-7 in 2D tissue culture plastics (TCP) and 3D PCL
fibrous scaﬀolds (PCL) were measured at indicated time points by CellTiter-Blue
assay. Results were shown as mean  standard deviation. Statistical significance
of the diﬀerences between cells on TCP and PCL is indicated by two asterisks
(P o 0.005, n = 3).
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attachment-independent manner and form floating spherical
colonies, which are termed mammospheres.25 Therefore the
mammosphere formation assay is often used to identify and
enrich CSCs. To further confirm whether the PCL fibrous
scaﬀolds culture system increases the size of CSCs population,
we measured the mammosphere formation ability of MCF-7
cells from TCP and PCL fibrous scaﬀolds. We found that the
MCF-7 cells from PCL fibrous scaﬀolds formed approximately
2.0-fold more mammospheres than control cells from TCP
(Fig. 5a). The sphere formation eﬃciency of T47D and SK-BR-3
from PCL fibrous scaﬀolds increased to 1.81  1.07% and
3.44  0.42%, relative to 1.07  0.50% and 2.51  0.16% for
cells on TCP, respectively (Fig. 5b and c). Some of those spheres
have a large size of around 100 mm. These spheres probably
came from multiple cells fusion.34,35 Those data suggests that
CSCs expanded in those mammary cancer cell lines when
cultured in electrospun PCL fibrous scaﬀolds.
OCT3/4 and SOX2 function cooperatively to regulate their
own transcription and the transcription of a large set of other
genes, which control the self-renewal and pluripotency of stem
cells.36 SOX4 functions in the progression of breast cancer by
orchestrating EMT.37 CD49f has been used for enrichment of
normal cells and CSCs,38,39 which maintains the pluripotency
and stemness through the direct regulation of OCT4 and SOX2.40
In our study, transcriptional factors related to stem cells, including
SOX2 and OCT3/4, and breast CSC signatures, including SOX4 and
CD49f, were enhanced in MCF-7 cultured on fibrous scaﬀolds by
1.77  0.25-fold, 2.22  0.23-fold, 1.56  0.25-fold, and 2.92 
0.33-fold, respectively, relative to cells on TCP (Fig. 5a). In addition,
among stemness related genes, only SOX2 were upregulated in
T47D from PCL fibrous scaﬀolds, while OCT3/4, SOX2, and CD49f
were upregulated in SK-BR-3 cells from PCL fibrous scaﬀolds,
relative to cells from TCP (Fig. 5b).
To investigate whether the eﬀect of 3D PCL fibrous scaﬀolds
culture on CSCs expansion is cell-phenotype specific, we
examined how CSCs respond to the fibrous scaﬀold culture in
a highly malignant basal-type cell line, MDA-MB-231 cells.
ALDEFLUOR assay, mammosphere formation assay, and gene
expression patterns all show that MDA-MB-231 cells on PCL
fibrous scaﬀolds increased CSCs population relative to cells
on TCP (Fig. S9, ESI†). Although the proportion of CSCs in
MDA-MB-231 cells cultured on PCL fibrous scaﬀolds increases
not as dramatically as in epithelial cell lines, the same trend of
changes in the CSC population in several breast cancer cell
lines cultured indicates that this phenomenon is not cell-
phenotype specific.
Studies have demonstrated that tumor cells cultured in 3D
systems displayed properties of increased malignancy and drug
Fig. 4 Epithelial breast cancer cell lines, MCF-7, T47D, and SK-BR-3 cultured on PCL fibrous scaﬀolds (PCL) increased ALDH-positive population compared with
counterparts cultured on TCP. (a–c) After being cultured for 6 days on PCL and TCP without passage, cells were harvested and analyzed by ALDEFLUOR assay. The ALDH
inhibitor, diethylaminobenzaldehyde (DEAB) (15 mM), was added to the cell suspension in the ALDEFLUOR assay buﬀer with the substrate as a negative control.
Numbers indicate the percentages of cells in the gated area. (d–f) The percentage of ALDH-positive cells in MCF-7, T47D, and SK-BR-3 cells cultured on PCL and TCP.
Results were shown as mean  standard deviation. Statistical significance is indicated by double asterisks (P o 0.001, n = 3).
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resistance compared to standard 2D cultured tumor cells.16,18,41,42
Given the fact that CSCs are responsible for metastasis and
drug resistance, the expansion of CSCs in tumor cells cultured
in 3D may account for this change.
The enhancement of EMT-associated properties in cells from
PCL fibrous scaﬀolds
The EMT is a developmental process, in which epithelial cells
with tight cell junctions and relatively low migratory ability
convert to mesenchymal cells with migratory and invasive
phenotype. Recent studies demonstrate that during the
carcinoma progression, some tumor cells are undergoing the
EMT.43 The inducing factors of EMT include growth factors,
cell–matrix interaction, and hypoxia. In addition, EMTmay also
trigger the transformation of non-stem cancer cells to CSCs,
in which tumor cells are acquiring properties of invasion, drug-
resistance, chemo-resistance, and radio-resistance.26
We previously reported that culture on PCL fibrous scaﬀolds
with either aligned fibres or random fibres can stimulate
mouse mammary cell line H605 to undergo EMT.28 Here, we
investigated whether human epithelial-type breast cancer cell
lines MCF-7, T47D, and SK-BR-3 cultured on PCL fibrous
scaﬀolds were undergoing EMT.
A classical definition of EMT is a multiple step process, in
which cells acquire a mesenchymal morphology and then
demonstrate increased migration and invasion.44 MCF-7 cells
from PCL fibrous scaﬀolds were reseeded to TCP, of which about
10% demonstrated elongated spindle-like morphology (Fig. S5,
ESI†). There was no morphological change for reseeded T47D
and SK-BR-3 cells from fibrous scaﬀolds. Using Transwell assay,
Fig. 5 Epithelial breast cancer cell lines, MCF7, T47D, and SK-BR-3 on PCL fibrous scaﬀolds (PCL) increased the property of stemness. (a–c) Cells cultured on PCL and
TCP for 6 days without passage were harvested for mammoshpere formation assay. Mammospheres were observed under microscopy and enumerated. Results are
shown as mean  standard deviation. Statistical significance is indicated by single asterisk (Po 0.05, n = 6) or double asterisks (Po 0.005, n = 6). Scale bars indicate
100 mm. (d) SOX2, SOX4, OCT3/4, and CD49f expression in MCF-7, T47D, and SK-BR-3 cultured on PCL and TCP. Results are shown as mean  standard deviation.
Statistical significance is indicated by a single asterisk (P o 0.05, n = 3) or double asterisks (P o 0.005, n = 3).
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we measured the invasive property of MCF-7, T47D, and
SK-BR-3 cells, a characteristic associated with EMT. Cells from
PCL fibrous scaﬀolds showed significant increases in the
number of cells passing through the membrane (Fig. 6).
To further confirm that cells on PCL fibrous scaﬀolds were
undergoing EMT, we measured the transcriptions of EMT
related genes in cells from two diﬀerent culture conditions.
The expression of EMT related transcriptional factors, including
SLUG, SNAIL, TWIST1, TWIST2, ZEB1, ZEB2, and FOXC2, and
other EMT markers, including VIM and ITGA5, were signifi-
cantly upregulated in MCF-7 cells on PCL fibrous scaﬀolds in
comparison with cells cultured on TCP (Fig. 6b). In T47D cells
on PCL fibrous scaﬀolds, EMT related transcriptional factors,
SNAIL, TWIST1, TWIST2, and ZEB2 were upregulated, com-
pared to cells on TCP. In SK-BR-3 cells, only ZEB2, VIM, and
ITGA5 were upregulated. Meanwhile, the expression of the
epithelial marker, CDH-1 (E-cadherin), decreased in cells from
PCL fibrous scaﬀolds relative to cells from TCP. Indirect
immunofluorescence staining of cells with E-cadherin antibody
revealed that most of the cells, if not all, on fibrous scaﬀolds
still expressed E-cadherin protein (Fig. S6, ESI†). Western blot
analysis indicates that there is no significant change in protein
level for E-cadherin and vimentin in cells from fibrous scaﬀolds
relative to cells from TCP (Fig. S8, ESI†). It is probably because
the cells are still undergoing the early transition of EMT, which
is a relatively slow process. For example, TGF-b normally
induces EMT within about two weeks.45 The improvement of
invasion and enhancement of expression of EMT markers
suggests cells on PCL fibrous scaﬀolds were undergoing EMT
(Fig. 7).
It was reported that immortalized human mammary
epithelial cells undergoing EMT displayed a shift in CD44
expression from variant isoforms (CD44v) to the standard form
(CD44s).46 In the present study, we observed that CD44v,
CD44s and CD44t were all upregulated in cells cultured on
PCL fibrous scaﬀolds (Fig. S4, ESI†). CD24 regulates TGF-b3
and E-cadherin in oral epithelial cells during EMT.47 The
downregulation of CD24 and the upregulation of TGF-b3 in
cells cultured on fibrous scaﬀolds suggest that cells were
undergoing EMT (Fig. S4, ESI†).
MDA-MB-231 cells have basal-like properties and possess
mesenchymal phenotype due to high expression of vimentin.48,49
Indeed, the basal level of the EMT related gene in MDA-MB-231
cells is higher than in epithelial-like cells, MCF7, T47D, and
SK-BR-3. Culture on fibrous scaﬀolds further enhances the
expression of EMT related genes in MDA-MB-231 cells
(Fig. S9, ESI†). It is acknowledged that the EMT process is
related to stemness.26 If the increased CSCs came from the
transformation of non-stem cancer cells induced by EMT, CSCs
proportion in the mesenchymal-type cell line, MDA-MB-231,
would not change as dramatically as the epithelial-type cell
lines, because the mesenchymal cell line cannot undergo the
EMT process.
A previous study suggested that MCF-7 cells on 3D collagen
scaﬀolds were induced to undergo EMT may be due to the
adaption to the hypoxia condition.50 In our study most of the
cells localized on the surface of scaﬀolds, and a few cells
infiltrated into the lower layers, which is not suﬃcient to
induce the hypoxia condition. Therefore it might be other
factors rather than hypoxia that induced cells to undergo
EMT in this case. It is acknowledged that compressive
forces generated by the interaction between cells and their
surrounding environment can cause, either directly or
indirectly, alterations of cell in the structure and function of
ECM receptors to actively influence the signaling pathway. EMT
in the tumor environment is a force-dependent phenomenon.51
TGF-b studies revealed that dynamic compression and contrac-
tion of cell–matrix interaction activates latent ECM bound
TGF-b, thereby stimulating a feedback loop to induce EMT in
the cell itself.52,53 Further research will be required to elucidate
Fig. 6 Culture on PCL fibrous scaﬀolds (PCL) increases the invasion of MCF-7, T47D, and SK-BR-3 cells. (a–c) MCF-7, T47D, SK-BR-3 cells from PCL displayed higher
invasive capability in the Transwell invasion assay compared to counterparts from TCP. Cells that successfully migrated through the filter pores were fixed with 3.7%
paraformaldehyde and stained with 0.5% crystal violet in 2% ethanol. Scale bars indicate 100 mm. (d–f) The average number of migrated cells per field was assessed by
counting six random fields. Statistical significance is indicated by double asterisks (P o 0.001, n = 3).
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the detailed mechanism of how the 3D PCL fibrous scaﬀolds
induce cells to undergo EMT.
Although EMT can induce the conversion of non-stem
cancer cells to CSCs, a recent study suggests EMT and stemness
are not necessarily linked.54 In the present study, we found that
PCL fibrous scaﬀolds culture conditions increased CSCs prop-
erties and induced EMT. However, it is still unclear whether
that EMT and the increase of CSCs are two independent events
or two events with causal relationship. Further work needs to be
done to understand the relationship between EMT and the
increase of CSCs in electrospun PCL fibrous scaﬀolds.
Experimental
Preparation of electrospun PCL fibrous scaﬀolds
A 15% w/w solution of poly(e-caprolactone) (PCL) (Average Mn
ca. 60 kDa, Sigma), in 1,1,1,3,3,3-hexafluro-2-propanol (HFIP)
(Sigma Aldrich) was made. The electrospinning system is placed
Fig. 7 PCL fibrous scaﬀolds culture enhanced the expression of EMT related markers. Diﬀerential expressions of EMT markers were measured by qRT-PCR in MCF-7 (a),
T47D (b), and SK-BR-3 (c) from PCL and TCP. Results were shown as mean  standard deviation. Statistical significance is indicated by single asterisk (Po 0.05, n = 3) or
double asterisks (P o 0.005, n = 3).
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in a humidity-controlled chamber and schematically depicted in
Fig. 1a. The electrospinning process was conducted as follows: the
polymer solution was transferred to a 1.0 mL plastic syringe (BD)
with a 21 G blunt needle (BD precision glide). A syringe driver was
used to control the solution flow rate at 15 mL min1. A high
voltage supply (HVR Orlando, FL) was used to build up a voltage of
6–7 kV electro filed between the needle and the grounded
collector. The distance between the collector and needle was fixed
at 10 cm. The PCL fibrous scaﬀold was fertilized by immersing
into 75% ethanol for 20 min, dried overnight and then irradiated
under ultraviolet light for 20 min in a laminar flow hood.
Cell culture
Human breast cancer cell lines MCF-7, T47D, SK-BR-3, and
MB-MDA-231 were purchased from the American Type Culture
Collection. MCF-7 and MDA-MB-231 cells were cultured in
Dulbecco’s modified Eagle’s medium (DMEM, #D6046, Sigma-
Aldrich) supplemented with 10% heat inactivated fetal bovine
serum (Hyclone, Thermo Scientific), 100 U mL1 penicillin
and 100 mg mL1 streptomycin (Gibco BRL, Invitrogen Corp.,
Carlsbad, CA, USA). T47D was maintained in RPMI-1604 media
(Sigma-Aldrich) containing 10% FBS, 100 U mL1 penicillin and
100 mg mL1 streptomycin. SK-BR-3 was maintained in KBR3
cells grown in McCoy’s 5A (Sigma-Aldrich) supplemented with
10% FBS, 10% FBS and 100 U mL1 penicillin and 100 mg mL1
streptomycin. Cells were cultured in a 5% CO2 humidified
incubator at 37 1C. Sterilized PCL fibre scaﬀolds were soaked
in media 30 min prior to cell seeding. Cells in the exponential
growth phase were trypsinized using 0.25% trypsin and seeded
on a PCL fibrous scaﬀold at a density of 5.2  103 cells per cm2.
The cells used in experiments were cultured on PCL and TCP for
6 days without passage, unless otherwise specified.
Confocal and scanning electron microscopy studies
Cells on PCL fibre scaﬀolds were rinsed with phosphate buﬀered
saline (PBS) twice and fixed with 4% paraformaldehyde for 20min
at room temperature. Then scaﬀolds were rinsed with PBS. Cells
were permeabilized with 0.2% Triton X-100 for 10 min. To prevent
non-specific labeling, 3% bovine serum albumin (BSA) in PBS was
applied as a blocking buﬀer for 20 min. Actin cytoskeleton was
stained with rhodamine phalloidin (Cytoskeleton Inc.) (1 : 200)
in a blocking buﬀer for 20 min, and nuclei were stained with
40,6-diamidino-2-phenylindole (DAPI) (Invitrogen) in a blocking
buﬀer for 10 min. The fluorescence was visualized and captured
under confocal microscope (Olympus IX81) with DAPI filter and
Cy3 filter set. The morphologies of PCL fibre scaﬀolds were
examined using a field emission scanning electron microscope
(FEI Quanta 200 ESEM). PCL scaﬀold samples were dried with
nitrogen, and coated with gold for 30 seconds with sputter
coater. To examine the uniformity of the fibre diameters several
areas were imaged. Fibre diameters were measured using
image J (National Institutes of Health).
ALDEFLUOR assay
The ALDEFLUOR kit (Stem Cell Technologies, Durham, NC,
USA) was used to identify the cancer stem cell population with
high ALDH enzyme activity. Briefly, the cells were suspended in
ALDEFLUOR assay buﬀer containing ALDH substrate BAAA (1 mM)
at a concentration of 1  106 cells per mL1 and incubated for
45 min at 37 1C. As a negative control, the ALDH inhibitor,
diethylaminobenzaldehyde (DEAB) (15 mM), was added to the cell
suspension in ALDEFLUOR assay buﬀer with BAAA. A Cytomics
FC500 flow cytometry system (Beckman Coulter Inc., Miami, FL,
USA) was used to detect the ALDH-positive cell population.
Cell proliferation assay
The eﬀect of PCL fibre scaﬀolds on cell growth was assessed by
CellTiter-Bluet Cell Viability Assay (Promega, Madison, WI).
The cell titer blue reagent was added to the medium directly
(100 mL per 1 mL medium) and incubated for four hours at
37 1C. Fluorescence at 560ex/590em nm filter setting was measured
using a Tecan infinite M200 plate reader (Tecan, Salzburg, Austria).
After correction of background fluorescence, the intensity of
fluorescence for each sample was normalized by the first day
intensity of fluorescence. The cell viabilities at days 1, 3, 5, 7, 9,
11, and 13 were determined. Three independent experiments
were determined for each case.
Mammosphere formation assay
Cells from 2D culture or 3D PCL fibrous scaﬀolds were plated in
ultralow attachment six-well plates (Corning, Acton, MA, USA)
at a density of 10 000 cells per mL1 for MCF-7 and 1000 cells
per mL1 for MDA-MB-231 in serum-free DMEM/F12 medium
(Invitrogen, Carlsbad, CA, USA) supplemented with 20 ng mL1
epidermal growth factor (Sigma, St Louis, MO, USA),
10 ng mL1 basic fibroblast growth factor (Sigma), 5 mg mL1
insulin (Sigma), 1  B27 supplement (Invitrogen) and 0.4%
bovine serum albumin (Sigma). Cells were cultured in a 5% CO2
humidified incubator at 37 1C for a week. The number of
mammospheres was counted under microscopy. Three inde-
pendent experiments were performed for each group.
RNA extraction and quantitative reverse-transcription PCR
Total RNA was isolated using an RNeasy mini purification kit
(Qiagen). Quantitative reverse-transcription PCR (qRT-PCR) was
performed in two steps. Isolated RNA was reverse-transcribed
using a qScriptt cDNA synthesis kit (Quanta Biosciences Inc.)
and then Quantitative (real-time) PCR was performed using a
Bio-Rad iCycler with a My iQt camera detection system and the
method used was 40 cycles of PCR (95 1C for 30 s, 60 1C for 15 s,
72 1C for 30 s), after an initial denaturation step of 5 min at
95 1C. In a 25 mL total volume of the reaction mixture, 12.5 mL
iQ SYBR-Greent SuperMix (Bio-Rad), 400 nM of both forward
and reverse primers (Table S1, ESI†) and the cDNA template
at a final concentration of 25 ng mL1 were employed. Data
analysis was performed using the 2DDCT method for relative
quantification,55 and all samples were normalized to GAPDH
expression as the internal control.
Transwell invasion assay
The invasion chamber consisted of a cell culture insert with a
membrane pore size of 8 mm in a 24-well plate (BD Biocoatt
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Matrigelt Invasion Chamber, BD Biosciences, Franklin
Lakes, NJ). Cells cultured in 2D and 3D were trypsinized and
washed by PBS. Then cells were plated in the top chamber with
Matrigel-coated membrane at a density of 2.5  105 cells per
well for MCF-7 and 1  106 cells per well for SK-BR-3 and T47D.
Cells were plated in the serum free medium and medium with
10% FBS was used as a chemoattractant in the lower chamber.
The cells were incubated in a 5% CO2 humidified incubator at
37 1C for 72 h. Cells that fail to invade through pores were
removed using a cotton swab. Cells on the lower surface of the
membrane were fixed with 3.7% paraformaldehyde and stained
with 0.5% crystal violet in 2% ethanol and counted under a
microscope.
Statistical analysis
All assays were performed in triplicate unless otherwise stated.
Data are indicated as mean  standard deviation. Compari-
sons between two groups were done using unpaired Student’s
t-test.
Conclusions
Cancer stem cells, which are responsible for the tumorigenesis,
chemo-resistance, radio-resistance, and metastases, play a vital
role in the tumor initiation and regression. Previous studies
suggested that cells in traditional 2D culture fail to represent
in vivo tumor cells, due to the loss of the malignancy. In the
present study, using the electrospinning process, we generated
PCL fibrous scaﬀolds for 3D cell culture. Three epithelial-type
breast cancer cell lines, including MCF-7, T47D, SK-BR-3,
cultured on PCL fibrous scaﬀolds showed increased CSCs
population relative to cells cultured on TCP, which may likely
attribute to the EMT process.
Recently we have developed a set of mathematical models
with two negative feedbacks to explore essential biological
factors that control the CSC population during tumor growth,
in which an excellent agreement with experimental data has
been achieved. To characterize the underlying features of CSCs
induced by 3D PCL fibrous scaﬀolds, we plan next to extend
mathematical models as proposed by including the transfor-
mation from non-stem cells to CSCs to further investigate
whether the enrichment of CSCs by 3D PCL fibre scaﬀolds is
primarily due to transformation of non-stem cells to CSCs, or
increasing symmetric division or diﬀerentiation rates of CSCs,
or the combination of these diﬀerent factors. With this data, we
anticipated that PCL fibrous scaﬀolds culture system, in which
cells demonstrate higher malignancy and the expansion of
CSCs, could be used as a useful scaﬀold for the evaluation of
novel anti-cancer drugs and the enrichment of cancer stem
cells in vitro.
Acknowledgements
We gratefully acknowledge the financial support of this work by
NIH grant (3P20RR017698-08) to HC and QW, the American
Cancer Society Research Award (RSG-10-067-01-TBE) to HC,
and the support to QW from the US NSF CHE-0748690 and
the Camille Dreyfus Teacher Scholar Award.
References
1 J. B. Kim, Semin. Cancer Biol., 2005, 15, 365–377.
2 L. G. Griﬃth and M. A. Swartz, Nat. Rev. Mol. Cell Biol., 2006,
7, 211–224.
3 C. S. Szot, C. F. Buchanan, J. W. Freeman and
M. N. Rylander, Biomaterials, 2011, 32, 7905–7912.
4 V. N. Anisimov, S. V. Ukraintseva and A. I. Yashin, Nat. Rev.
Cancer, 2005, 5, 807–819.
5 A. Rangarajan and R. A. Weinberg, Nat. Rev. Cancer, 2003, 3,
952–959.
6 A. F. Frijhoﬀ, C. J. Conti and A. M. Senderowicz, Mol.
Carcinog., 2004, 39, 183–194.
7 G. M. de Jong, F. Aarts, T. Hendriks, O. C. Boerman and
R. P. Bleichrodt, J. Surg. Res., 2009, 154, 167–176.
8 A. Rangarajan, S. J. Hong, A. Giﬀord and R. A. Weinberg,
Cancer Cell, 2004, 6, 171–183.
9 O. Hartman, C. Zhang, E. L. Adams, M. C. Farach-Carson,
N. J. Petrelli, B. D. Chase and J. F. Rabolt, Biomaterials, 2010,
31, 5700–5718.
10 C. S. Szot, C. F. Buchanan, P. Gatenholm, M. N. Rylander
and J. W. Freeman, Mater. Sci. Eng., C, 2011, 31, 37–42.
11 D. Han and P. I. Gouma, Nanomedicine, 2006, 2, 37–41.
12 D. R. Nisbet, J. S. Forsythe, W. Shen, D. I. Finkelstein and
M. K. Horne, J. Biomater. Appl., 2009, 24, 7–29.
13 A. Cipitria, A. Skelton, T. R. Dargaville, P. D. Dalton and
D. W. Hutmacher, J. Mater. Chem., 2011, 21, 9419.
14 K. M. Yamada and E. Cukierman, Cell, 2007, 130, 601–610.
15 X. Wang, L. Sun, M. V. Maﬃni, A. Soto, C. Sonnenschein
and D. L. Kaplan, Biomaterials, 2010, 31, 3920–3929.
16 C. Fischbach, R. Chen, T. Matsumoto, T. Schmelzle,
J. S. Brugge, P. J. Polverini and D. J. Mooney, Nat. Methods,
2007, 4, 855–860.
17 M. A. D. Faute, L. Laurent, D. Ploton, M. F. Poupon,
J. C. Jardillier and H. Bobichon, Clin. Exp. Metastasis,
2002, 19, 161–168.
18 M. Leung, F. M. Kievit, S. J. Florczyk, O. Veiseh, J. Wu,
J. O. Park and M. Zhang, Pharm. Res., 2010, 27, 1939–1948.
19 S. M. Pollard, K. Yoshikawa, I. D. Clarke, D. Danovi,
S. Stricker, R. Russell, J. Bayani, R. Head, M. Lee,
M. Bernstein, J. A. Squire, A. Smith and P. Dirks, Cell Stem
Cell, 2009, 4, 568–580.
20 S. Saha, P.-K. Lo, X. Duan, H. Chen and Q. Wang, Integr.
Biol., 2012, 4, 897–904.
21 B. K. Abraham, P. Fritz, M. McClellan, P. Hauptvogel,
M. Athelogou and H. Brauch, Clin. Cancer Res., 2005, 11,
1154–1159.
22 X. X. Li, M. T. Lewis, J. Huang, C. Gutierrez, C. K. Osborne,
M. F. Wu, S. G. Hilsenbeck, A. Pavlick, X. M. Zhang,
G. C. Chamness, H. Wong, J. Rosen and J. C. Chang,
J. Natl. Cancer Inst., 2008, 100, 672–679.
23 M. Diehn, R. W. Cho, N. A. Lobo, T. Kalisky, M. J. Dorie,
A. N. Kulp, D. L. Qian, J. S. Lam, L. E. Ailles, M. Z. Wong,
Integrative Biology Paper
Pu
bl
ish
ed
 o
n 
01
 M
ar
ch
 2
01
3.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f S
ou
th
 C
ar
ol
in
a 
Li
br
ar
ie
s o
n 
17
/0
3/
20
15
 1
6:
30
:1
3.
 
View Article Online
This journal is c The Royal Society of Chemistry 2013 Integr. Biol., 2013, 5, 768--777 777
B. Joshua, M. J. Kaplan, I. Wapnir, F. M. Dirbas, G. Somlo,
C. Garberoglio, B. Paz, J. Shen, S. K. Lau, S. R. Quake,
J. M. Brown, I. L. Weissman and M. F. Clarke, Nature, 2009,
458, 780–783.
24 C. Ginestier, M. H. Hur, E. Charafe-Jauﬀret, F. Monville,
J. Dutcher, M. Brown, J. Jacquemier, P. Viens, C. G. Kleer,
S. Liu, A. Schott, D. Hayes, D. Birnbaum, M. S. Wicha and
G. Dontu, Cell Stem Cell, 2007, 1, 555–567.
25 G. Dontu, W. M. Abdallah, J. M. Foley, K. W. Jackson,
M. F. Clarke, M. J. Kawamura and M. S. Wicha, Genes
Dev., 2003, 17, 1253–1270.
26 S. A. Mani, W. Guo, M. J. Liao, E. N. Eaton, A. Ayyanan,
A. Y. Zhou, M. Brooks, F. Reinhard, C. C. Zhang,
M. Shipitsin, L. L. Campbell, K. Polyak, C. Brisken, J. Yang
and R. A. Weinberg, Cell, 2008, 133, 704–715.
27 P. P. Provenzano, K. W. Eliceiri, J. M. Campbell,
D. R. Inman, J. G. White and P. J. Keely, BMC Med., 2006,
4, 38.
28 S. Saha, X. Duan, L. Wu, P. K. Lo, H. Chen and Q. Wang,
Langmuir, 2012, 28, 2028–2034.
29 J. P. Chute, G. G. Muramoto, J. Whitesides, M. Colvin,
R. Safi, N. J. Chao and D. P. McDonnell, Proc. Natl. Acad.
Sci. U. S. A., 2006, 103, 11707–11712.
30 M. S. Wicha, C. Ginestier, E. Charaﬀe-Jauﬀret, F. I. Tarpin,
G. Dontu and F. Iovino, Clin. Exp. Metastasis, 2008, 25, 11.
31 Y. Wang, H. Zhe, P. Gao, N. Zhang, G. Li and J. Qin, Dis.
Esophagus, 2012, 25, 560–565.
32 A. K. Croker, D. Goodale, J. Chu, C. Postenka, B. D. Hedley,
D. A. Hess and A. L. Allan, J. Cell. Mol. Med., 2009, 13,
2236–2252.
33 R. W. Storms, A. P. Trujillo, J. B. Springer, L. Shah,
O. M. Colvin, S. M. Ludeman and C. Smith, Proc. Natl. Acad.
Sci. U. S. A., 1999, 96, 9118–9123.
34 B. A. Reynolds and R. L. Rietze, Nat. Methods, 2005, 2,
333–336.
35 G. G. Jinesh, W. Choi, J. B. Shah, E. K. Lee, D. L. Willis and
A. M. Kamat, Cell Death Diﬀer., 2012, 20, 382–395.
36 S. Okumura-Nakanishi, M. Saito, H. Niwa and F. Ishikawa,
J. Biol. Chem., 2005, 280, 5307–5317.
37 J. Zhang, Q. Liang, Y. Lei, M. Yao, L. Li, X. Gao, J. Feng,
Y. Zhang, H. Gao, D. X. Liu, J. Lu and B. Huang, Cancer Res.,
2012, 72, 4597–4608.
38 J. Stingl, P. Eirew, I. Ricketson, M. Shackleton, F. Vaillant,
D. Choi, H. I. Li and C. J. Eaves, Nature, 2006, 439, 993–997.
39 P. K. Lo, D. Kanojia, X. Liu, U. P. Singh, F. G. Berger,
Q. Wang and H. Chen, Oncogene, 2012, 31, 2614–2626.
40 K. R. Yu, S. R. Yang, J. W. Jung, H. Kim, K. Ko, D. W. Han,
S. B. Park, S. W. Choi, S. K. Kang, H. Scholer and K. S. Kang,
Stem Cells, 2012, 30, 876–887.
41 J. L. Horning, S. K. Sahoo, S. Vijayaraghavalu, S. Dimitrijevic,
J. K. Vasir, T. K. Jain, A. K. Panda and V. Labhasetwar, Mol.
Pharmaceutics, 2008, 5, 849–862.
42 F. Xu and K. J. Burg, Cytotechnology, 2007, 54, 135–143.
43 E. Tomaskovic-Crook, E. W. Thompson and J. P. Thiery,
Breast Cancer Res., 2009, 11, 213.
44 J. P. Thiery, Nat. Rev. Cancer, 2002, 2, 442–454.
45 M. Oft, J. Peli, C. Rudaz, H. Schwarz, H. Beug and
E. Reichmann, Genes Dev., 1996, 10, 2462–2477.
46 R. L. Brown, L. M. Reinke, M. S. Damerow, D. Perez, L. A.
Chodosh, J. Yang and C. Cheng, J. Clin. Invest., 2011, 121,
1064–1074.
47 P. Ye, M. A. Nadkarni and N. Hunter, Biochem. Biophys. Res.
Commun., 2006, 349, 229–235.
48 M. H. Chen, G.W. Yip, G. M. Tse, T. Moriya, P. C. Lui, M. L. Zin,
B. H. Bay and P. H. Tan, Mod. Pathol., 2008, 21, 1183–1191.
49 K. Vuoriluoto, H. Haugen, S. Kiviluoto, J. P. Mpindi, J. Nevo,
C. Gjerdrum, C. Tiron, J. B. Lorens and J. Ivaska, Oncogene,
2011, 30, 1436–1448.
50 M. H. Yang and K. J. Wu, Cell Cycle, 2008, 7, 2090–2096.
51 J. I. Lopez, J. K. Mouw and V. M. Weaver, Oncogene, 2008, 27,
6981–6993.
52 R. G. Wells and D. E. Discher, Sci. Signaling, 2008, 1, pe13.
53 P. J. Wipﬀ, D. B. Rifkin, J. J. Meister and B. Hinz, J. Cell Biol.,
2007, 179, 1311–1323.
54 O. H. Ocana, R. Corcoles, A. Fabra, G. Moreno-Bueno,
H. Acloque, S. Vega, A. Barrallo-Gimeno, A. Cano and
M. A. Nieto, Cancer Cell, 2012, 22, 709–724.
55 K. J. Livak and T. D. Schmittgen, Methods, 2001, 25, 402–408.
Paper Integrative Biology
Pu
bl
ish
ed
 o
n 
01
 M
ar
ch
 2
01
3.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f S
ou
th
 C
ar
ol
in
a 
Li
br
ar
ie
s o
n 
17
/0
3/
20
15
 1
6:
30
:1
3.
 
View Article Online
